Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602535.pdf
Reference66 articles.
1. Akashi T, Ito E, Eishi Y, Koike M, Nakamura K, Burgeson RE (2001) Reduced expression of laminin alpha 3 and alpha 5 chains in non-small cell lung cancers. Jpn J Cancer Res 92: 293–301
2. Behe M, Behr T (2002) Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Biopolymer 66: 399–418
3. Bold RJ, Ishizuka J, Rajaraman S, Perez-Polo R, Townsend CM, Thompson JC (1995) Nerve growth factor as a mitogen for a pancreatic carcinoid cell line. J Neurochem 64: 2622–2628
4. Børset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A (1996) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in myeloma cell lines. J Biol Chem 271: 24655–24661
5. Browning JL, Miatkowski K, Sizing I, Griffiths D, Zafari M, Benjamin CD, Meier W, Mackay F (1996) Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med 183: 867–878
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. LAMA5 promotes cell proliferation and migration in ovarian cancer by activating Notch signaling pathway;The FASEB Journal;2023-08
2. The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer;Biochemical and Biophysical Research Communications;2022-12
3. Cytokine Gene Polymorphism and Cancer Risk: A Promising Tool for Individual Susceptibility and Prognostic Implications;Genetic Polymorphisms - New Insights;2022-05-04
4. Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma;Frontiers in Molecular Biosciences;2021-03-08
5. Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus;Frontiers in Oncology;2020-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3